Bamburgh Marrsh

Bamburgh Marrsh was a U.S. oral-fluid diagnostics company focused on saliva-based sample collection devices and non-invasive diagnostic testing. The company appears to have been founded in 2002 in Vancouver, Washington, and developed or licensed technologies for saliva collection and testing in infectious disease, neurology, and women's health applications. Publicly available sources indicate Bamburgh Marrsh later operated as, or became a subsidiary of, Oasis Diagnostics, which markets saliva collection and oral-fluid diagnostic products. Its work included proprietary saliva sampling technology, lateral-flow style testing concepts, and licensed U.S. Navy technologies for anthrax vaccine efficacy and tuberculosis testing. Based on available evidence, Bamburgh Marrsh is best understood as an early-stage diagnostics operating entity or subsidiary rather than a standalone therapeutics biotech company.